vimarsana.com

Page 9 - Decision Resources Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Novartis iptacopan meets primary endpoints in Phase II study in rare kidney disease C3 glomerulopathy (C3G)

/PRNewswire/ Novartis today announced that a Phase II study of investigational iptacopan (LNP023) – a first-in-class, oral, selective factor B inhibitor –.

Czech republicUnited statesNewcastle upon tyneUnited kingdomJulie masowJamie bennettEdwin wongSloan simpsonJohn tsaiPrnewswire novartisHead of global drug developmentExchange commissionNewcastle universityNational kidney foundationNational renal complement therapeutics centreNj novartis pharmaceuticals corporation

Novartis iptacopan meets primary endpoints in Phase II study in rare kidney disease C3 glomerulopathy (C3G)

/PRNewswire/ Novartis today announced that a Phase II study of investigational iptacopan (LNP023) – a first-in-class, oral, selective factor B inhibitor –.

Czech republicUnited statesNewcastle upon tyneUnited kingdomJulie masowJamie bennettEdwin wongSloan simpsonJohn tsaiPrnewswire novartisHead of global drug developmentExchange commissionNewcastle universityNational kidney foundationNational renal complement therapeutics centreNj novartis pharmaceuticals corporation

4 Best Practices to Foster Virtual Care Transformation for Providers

Justin Miller, Vice President of Customer Success at eVisit shares four ways to help foster a virtual care transformation.

Mckinsey companyDecision resources groupBanner healthForma user group showcaseVirtual careEnvision healthcareUser groupTechnical supportHarvard business review

ThoughtWorld for iOS debuts on the App Store

/PRNewswire/ ThoughtWorld is now at your fingertips. The social sharing site that features interactive virtual graphics and anonymous posting has landed on.

Laguna niguelUnited statesNew yorkOrange countyRobert mingSanford cameronRobert mingisFounding partner of quadrant law groupAssociation of california citiesAbt bio pharma solutionsHotgrinds incDecision resources group manhattan researchWorld founderFounding partnerQuadrant law groupCalifornia cities

ThoughtWorld for iOS debuts on the App Store

/PRNewswire/ ThoughtWorld is now at your fingertips. The social sharing site that features interactive virtual graphics and anonymous posting has landed on.

Laguna niguelUnited statesNew yorkOrange countyRobert mingSanford cameronRobert mingisFounding partner of quadrant law groupAssociation of california citiesAbt bio pharma solutionsHotgrinds incDecision resources group manhattan researchWorld founderFounding partnerQuadrant law groupCalifornia cities

vimarsana © 2020. All Rights Reserved.